The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells

Imagem de Miniatura
Arquivos
art_PALADINO_The_Immunomodulatory_Potential_of_Whartons_Jelly_Mesenchymal_StemStromal_2019.PDF (1.66 MB)
Citações na Scopus
29
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
HINDAWI LTD
Autores
RODRIGUES, Juliana de Moraes
SILVA, Aline da
GOLDBERG, Anna Carla
Citação
STEM CELLS INTERNATIONAL, article ID 3548917, 7p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The benefits attributed to mesenchymal stem/stromal cells (MSC) in cell therapy applications are mainly attributed to the secretion of factors, which exhibit immunomodulatory and anti-inflammatory effects and stimulate angiogenesis. Despite the desirable features such as high proliferation levels, multipotency, and immune response regulation, there are important variables that must be considered. Although presenting similar morphological aspects, MSC collected from different tissues can form heterogeneous cellular populations and, therefore, manifest functional differences. Thus, the source of MSC should be a factor to be considered in the development of novel therapies. The following text presents an updated review of recent research outcomes related to Wharton's jelly mesenchymal stem/stromal cells (WJ-MSC), harvested from umbilical cords and considered novel and potential candidates for the development of cell-based approaches. This text highlights information on how WJ-MSC affect immune responses in comparison with other sources of MSC.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/33208
Referências
  1. Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
  2. Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007
  3. Amari A, 2015, CELL IMMUNOL, V293, P59, DOI 10.1016/j.cellimm.2014.12.003
  4. Arnous S, 2011, REGEN MED, V6, P525, DOI [10.2217/RME.11.29, 10.2217/rme.11.29]
  5. Ayenehdeh JM, 2017, IMMUNOL LETT, V188, P21, DOI 10.1016/j.imlet.2017.05.006
  6. Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675
  7. Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006
  8. Bhansali A, 2014, CELL TRANSPLANT, V23, P1075, DOI 10.3727/096368913X665576
  9. Bharti D, 2018, CELL TISSUE RES, V372, P51, DOI 10.1007/s00441-017-2699-4
  10. Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
  11. Bieback K, 2008, BIO-MED MATER ENG, V18, pS71
  12. Bunnell BA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt34
  13. Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135
  14. Choo KB, 2014, INT J MED SCI, V11, P1201, DOI 10.7150/ijms.8356
  15. Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657
  16. Davies JE, 2017, STEM CELL TRANSL MED, V6, P1620, DOI 10.1002/sctm.16-0492
  17. Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
  18. Donders R, 2018, STEM CELLS DEV, V27, P65, DOI 10.1089/scd.2017.0029
  19. Freedman MS, 2010, MULT SCLER J, V16, P503, DOI 10.1177/1352458509359727
  20. Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051
  21. Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696
  22. Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12
  23. Hong JW, 2017, YONSEI MED J, V58, P1031, DOI 10.3349/ymj.2017.58.5.1031
  24. Hoogduijn MJ, 2010, INT IMMUNOPHARMACOL, V10, P1496, DOI 10.1016/j.intimp.2010.06.019
  25. Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x
  26. Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272
  27. Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586
  28. Kalaszczynska I, 2015, BIOMED RES INT, DOI 10.1155/2015/430847
  29. Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286
  30. Karaoz E, 2017, TURK J HEMATOL, V34, P213, DOI 10.4274/tjh.2016.0171
  31. Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248
  32. Khong SML, 2019, STEM CELLS, V37, P240, DOI 10.1002/stem.2934
  33. Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104
  34. Le Blanc K, 2004, SCAND J IMMUNOL, V60, P307, DOI 10.1111/j.0300-9475.2004.01483.x
  35. Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3
  36. Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611
  37. LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
  38. Luz-Crawford P, 2016, STEM CELLS, V34, P456, DOI 10.1002/stem.2244
  39. Manochantr S, 2013, INTERN MED J, V43, P430, DOI 10.1111/imj.12044
  40. Meesuk Ladda, 2016, Biochem Biophys Rep, V8, P34, DOI 10.1016/j.bbrep.2016.07.019
  41. Mennan C, 2016, FEBS OPEN BIO, V6, P1054, DOI 10.1002/2211-5463.12104
  42. Mesples Alejandro, 2013, Med Sci Monit, V19, P852, DOI 10.12659/MSM.889525
  43. Mun CH, 2018, TISSUE ENG REGEN MED, V15, P771, DOI 10.1007/s13770-018-0147-5
  44. Nanaev AK, 1997, PLACENTA, V18, P53, DOI 10.1016/S0143-4004(97)90071-0
  45. Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080
  46. Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
  47. OWEN M, 1988, J CELL SCI, P63
  48. Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857
  49. Paladino FV, 2017, STEM CELLS INT, DOI 10.1155/2017/8492797
  50. Paladino FV, 2016, CELL TISSUE BANK, V17, P123, DOI 10.1007/s10561-015-9525-6
  51. Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]
  52. Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x
  53. Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005
  54. Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114
  55. Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
  56. Ren HJ, 2016, STEM CELLS INT, DOI 10.1155/2016/3516574
  57. Ringden O., 2011, CLIN HAEMATOL, V24, P65, DOI 10.1016/J.BEHA.2011.01.003
  58. Schugar RC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/789526
  59. Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943
  60. Sriramulu Sushmitha, 2018, Int J Hematol Oncol Stem Cell Res, V12, P230
  61. Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
  62. Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002
  63. Sun LY, 2010, ARTHRITIS RHEUM-US, V62, P2467, DOI 10.1002/art.27548
  64. Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68
  65. TAKECHI K, 1993, PLACENTA, V14, P235, DOI 10.1016/S0143-4004(05)80264-4
  66. Tipnis S, 2010, IMMUNOL CELL BIOL, V88, P795, DOI 10.1038/icb.2010.47
  67. Torkaman M, 2017, CELL IMMUNOL, V311, P1, DOI 10.1016/j.cellimm.2016.09.012
  68. Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416
  69. Valencic E, 2010, CYTOTHERAPY, V12, P154, DOI 10.3109/14653240903493417
  70. Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x
  71. Wang QS, 2016, HUM VACC IMMUNOTHER, V12, P85, DOI 10.1080/21645515.2015.1030549
  72. Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002
  73. Waterman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045590
  74. Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088
  75. Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028
  76. Xu L, 2017, STEM CELLS INT, DOI 10.1155/2017/3175748
  77. Yang YH, 2018, ACTA BIOMATER, V69, P71, DOI 10.1016/j.actbio.2017.12.043
  78. Yang YHK, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0876-3
  79. Yazid FB, 2014, CLIN ORAL INVEST, V18, P2103, DOI 10.1007/s00784-014-1207-4
  80. Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190
  81. Zhou CH, 2011, CELL IMMUNOL, V272, P33, DOI 10.1016/j.cellimm.2011.09.010

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros